Châtel-Soulet, H., Juge, S., Pereira, A. L., Seguin, J., Taher, A. E., Valigi, F., Jevtic, Z., Sivalingam, R., Bagger, F. O., Büschl, P., Almosailleakh, M., Tzankov, A., Tong, W., Kurokawa, M., Arrieta, C. N., Schwaller, J. (2025). Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome. Nature Communications. https://doi.org/10.1038/s41467-025-67611-w